← Feed

u/One-Dingo1220

3 theses · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$JFBr/pennystocksDDbullish
u/One-Dingo1220 · 101d ago2 prior · awaiting results

$JFB could be one of the most slept on setups on the Nasdaq right now 🔥

JFB Construction is merging with XTEND AI Robotics to create a combined entity trading as $XTND with $1.5B implied value. The combo of established commercial construction (78% of revenue, 93% YoY Q1 growth) with XTEND's deployed AI robotics (10,000+ systems, recent defense contracts totaling $18M+) represents a unique infrastructure-plus-defense play gaining institutional backing but limited attention.

original post →
$MDCXr/pennystocksDDbullish
u/One-Dingo1220 · 102d ago2 prior · awaiting results

$MDCX(Medicus Pharma — $22M non-dilutive financing secured, multiple clinical catalysts ahead on a sub $1 biotech

Medicus Pharma secured $22M non-dilutive debt financing with multiple clinical catalysts ahead: SkinJect Phase 2 data shows promising efficacy in BCC with no serious safety issues, Phase 2b registrational trial underway for Gorlin Syndrome, and pursuit of Orphan Drug Designation and Rare Pediatric Disease voucher could accelerate regulatory pathway. Teverelix advancing in prostate cancer positions company for multi-billion-dollar market opportunity.

original post →
$JFBr/pennystocksDDbullish
u/One-Dingo1220 · 103d ago2 prior · awaiting results

$JFB might be one of the most underrated setups on Nasdaq right now 🔥

JFB Construction is merging with XTEND AI Robotics to form XTND, combining a high-growth commercial builder (93% YoY Q1 revenue growth) with an AI-powered defense robotics company backed by institutional capital and government contracts. The combined entity's diversified revenue from both construction and defense tech positions it as undervalued ahead of the mid-2026 Nasdaq listing.

original post →

End of results.